| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10172043 | Respiratory Investigation | 2015 | 5 Pages |
Abstract
Our analysis demonstrated a lower incidence rate of disease flare after gefitinib discontinuation compared with the previous report, but the prognosis was similarly poor.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Hiroaki Akamatsu, Akira Ono, Takehito Shukuya, Asuka Tsuya, Yukiko Nakamura, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo, Takashi Nakajima, Nobuyuki Yamamoto, Toshiaki Takahashi,